‌

US Patent 12018003 Substituted pyrimidines as matrix metalloproteinase-9 hemopexin domain inhibitors

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Iwao Ojima0

Monaf Awwa0

Nicole Sampson0

Anushree Kamath0

Vincent Alford0

Jian Cao0

Xiadong Ren0

Date of Patent

June 25, 2024

0

Patent Application Number

173530750

Date Filed

June 21, 2021

0

Patent Citations

US Patent 7335653 Bis-aryl sulfonamides

0

US Patent 7351738 Substituted ureas and carbamates

0

US Patent 7429618 Potassium channel modulators

0

US Patent 7666855 2′-C-methyl nucleoside derivatives

0

US Patent 7923556 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors

0

US Patent 8148363 Heterocyclic compounds as factor IXA inhibitors

0

US Patent 8236809 Substituted 1,2,3-triazolopyrimidines for the inhibition of NAD(P)H oxidases and platelet activation

0

US Patent 8415321 Nucleoside derivatives for treatment of

0

...

Patent Primary Examiner

Douglas M Willis

0

CPC Code

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12018003 Substituted pyrimidines as matrix metalloproteinase-9 hemopexin domain inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool